Company: ADZCF
Filing Date: 2025-03-13
Form Type: 20-F
Source: 0001159508-25-000020
Chunk: 356

Company: DEUTSCHE BANK AKTIENGESELLSCHAFT
Filing Date: 2025-03-13
Form: 20-F
Chunk 356
---
 |     |                                 0 |     |                      952 |     |                        0 |     |    13,042 |
| Singapore                |     |                 61 |     |                      946 |     |                       738 |     |                                 0 |     |                      711 |     |                        0 |     |    11,397 |
| Hong Kong                |     |                  9 |     |                      559 |     |                       553 |     |                                 0 |     |                      329 |     |                        0 |     |     6,007 |
| Other Asia/Pacific       |     |                584 |     |                   10,353 |     |                     3,081 |     |                             3,449 |     |                    3,997 |     |                      326 |     |    47,032 |
| Other geographical areas |     |                160 |     |                    7,501 |     |                       158 |     |                               845 |     |                      222 |     |                    1,497 |     |    27,923 |
| Total                    |     |             21,655 |     |                  127,744 |     |                    34,236 |     |                            40,846 |     |                  104,649 |     |                    2,786 |     | 1,209,964 |

1 Includes stage 3 and stage 3 POCI loans at amortized cost amounting to € 15.6billion as of December 31, 2024

2 Includes stage 3 and stage 3 POCI loans at fair value through OCI amounting to € 60.7million as of December 31, 2024

3 Includes stage 3 and stage 3 POCI off-balance sheet exposure amounting to € 2.2billion as of December 31, 2024

4 Includes the effect of netting agreements and cash collateral received where applicable. Excludes derivatives qualifying for hedge accounting

5 Includes stage 3 and stage 3 POCI debt securities at amortized cost amounting to € 41.6million as of December 31, 2024

6 Includes stage 3 and stage 3 POCI debt securities at fair value through OCI amounting to € 25.6million as of December 31, 2024

7 Before reflection of collateral and limited to securities purchased under